TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
West Nile Virus
Merial S.A.S. publishes research in west nile virus
August 5th, 2008
"Successful vaccination against West Nile virus (WNV) requires induction of both neutralizing antibodies and cell-mediated immune responses. In this study, we have assessed the ability of a recombinant ALVAC (R)-WNV vaccine (RECOMBITEK (R) WNV) to elicit neutralizing antibodies and virus-specific cell-mediated immune responses in horses," researchers in Lyon, France report. "In addition, we examined whether prior exposure to ALVAC (R)-WNV vaccine would inhibit B and cell-mediated immune responses against the transgene product upon subsequent booster immunizations with the same vaccine. The results demonstrated that the recombinant ALVAC (R)-WNV vaccine induced...
Source: TB & Outbreaks Week (2008-08-05)
|
